Ziting Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ziting Wang has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Peter Wick
Empa – Swiss Federal Laboratories for Materials Science and Technology Laboratory For Nanomaterials in Health St. Gallen Switzerland
2 shared publications - Vera Maria Kissling
Swiss Federal Laboratories for Materials Science and Technology
2 shared publications Baierna Nuermaimaiti
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 102488, China
1 shared publicationBernadett Boda
Epithelix Sarl, 18 chemin des Aulx, 1228 Plan-les-Ouates, Switzerland
1 shared publicationGiacomo Reina
Nanomaterials in Health Laboratory, Department of Materials Meet Life
1 shared publication- Giacomo Reina
Empa – Swiss Federal Laboratories for Materials Science and Technology Laboratory For Nanomaterials in Health St. Gallen Switzerland
1 shared publication
Latest Publications
- Open Access
- 4 June 2026
- Published by Elsevier in Environment International
- Vol. 213, 110345
Stability and dermal safety of Ti3C2Tx MXenes for potential skin-interfaced biosensor applications
- 4 June 2026
- Published by Elsevier in Environment International
- Vol. 213, 110345
Open AccessStability and dermal safety of Ti3C2Tx MXenes for potential skin-interfaced biosensor applications
- 27 February 2026
- Published by Elsevier in Brain Research
- Vol. 1880, 150245
Anticoagulant peptide LR from Whitmania pigra ameliorates cerebral ischemia–reperfusion injury
- 27 February 2026
- Published by Elsevier in Brain Research
- Vol. 1880, 150245
Anticoagulant peptide LR from Whitmania pigra ameliorates cerebral ischemia–reperfusion injury
- Open Access
- 6 June 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (23) , 21426-21445
Silicon Carbide Nanowires Impair Mucociliary Clearance-Mediated Innate Immunity in Primary Human Bronchial Epithelial Cells
The respiratory tract possesses mucociliary-driven innate immune defense mechanisms that protect the lungs from harmful environmental exposures, but when damaged, increase susceptibility to respiratory infections and diseases. Inhalation exposure to certain nanomaterials has been shown to trigger fibrosis and other respiratory conditions. However, there is a limited understanding of whether nanomaterials can impair mucociliary defense in lungs and its underlying mechanism. Here, we first investigated the fate of zero-dimensional, one-dimensional, and two-dimensional silicon- and carbon-based nanomaterials (silicon carbide nanowires (SiC NWs), silicon dioxide (SiO2), multiwalled carbon nanotubes (MWCNTs), and graphene nanosheets) in airway mucus. The results demonstrated that only SiC NWs escaped through the mucus gel without interactions, suggesting their potential to diffuse across the protective mucus layer. The hydrophobicity of the SiC NWs, associated with the low abundance of polar surface groups, such as silanols, was mainly responsible for the observed shielding of particle interactions with mucus components. Furthermore, repeated exposure to SiC NWs in primary bronchial epithelial cell cultures revealed abnormal ciliary structure and significantly (p < 0.05) compromised mucociliary clearance functions, however, no such effects were evident for other particles. mRNA expression analysis showed a significant (p < 0.05) increase in FOX-J1 transcripts, suggesting transcriptional dysregulation of ciliogenesis after exposure to SiC NWs. Finally, SiC NWs reduced epithelial barrier integrity and promoted pro-inflammatory and pro-fibrotic responses. These findings unravel the hazardous potential of SiC NWs upon inhalation exposure and identify the breaching and impairment of the mucociliary innate defense as a key event in their respiratory toxicity.
- 6 June 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (23) , 21426-21445
Open AccessSilicon Carbide Nanowires Impair Mucociliary Clearance-Mediated Innate Immunity in Primary Human Bronchial Epithelial Cells
The respiratory tract possesses mucociliary-driven innate immune defense mechanisms that protect the lungs from harmful environmental exposures, but when damaged, increase susceptibility to respiratory infections and diseases. Inhalation exposure to certain nanomaterials has been shown to trigger fibrosis and other respiratory conditions. However, there is a limited understanding of whether nanomaterials can impair mucociliary defense in lungs and its underlying mechanism. Here, we first investigated the fate of zero-dimensional, one-dimensional, and two-dimensional silicon- and carbon-based nanomaterials (silicon carbide nanowires (SiC NWs), silicon dioxide (SiO2), multiwalled carbon nanotubes (MWCNTs), and graphene nanosheets) in airway mucus. The results demonstrated that only SiC NWs escaped through the mucus gel without interactions, suggesting their potential to diffuse across the protective mucus layer. The hydrophobicity of the SiC NWs, associated with the low abundance of polar surface groups, such as silanols, was mainly responsible for the observed shielding of particle interactions with mucus components. Furthermore, repeated exposure to SiC NWs in primary bronchial epithelial cell cultures revealed abnormal ciliary structure and significantly (p < 0.05) compromised mucociliary clearance functions, however, no such effects were evident for other particles. mRNA expression analysis showed a significant (p < 0.05) increase in FOX-J1 transcripts, suggesting transcriptional dysregulation of ciliogenesis after exposure to SiC NWs. Finally, SiC NWs reduced epithelial barrier integrity and promoted pro-inflammatory and pro-fibrotic responses. These findings unravel the hazardous potential of SiC NWs upon inhalation exposure and identify the breaching and impairment of the mucociliary innate defense as a key event in their respiratory toxicity.